Navigation Links
Men who takes risk is unlikely to impress women

Men always have appreciated the value of taking risks as very macho and manly. A recent study in the journal// Evolution and Human Behavior had pointed out that although men who take risk get more friends, women do not like to have them as spouses.

In the study carried out by the psychologists of University of Maine, males and females evaluated the attractiveness of risk takers as potential mates, and friends. Tasks were divided into heroic risk taking and non-heroic risk taking tasks on which people were asked to decide for same sex friends and opposite sex mates.

The results of the study show that males preferred non-heroic risk takers as mates and heroic risk takers as friends. While females preferred risk avoiders both as friends of similar sex as well as deciding for a mate from opposite sex.

So why do males prefer taking risks to impress and females don’t get sufficiently impressed to marry the risk taking male?

One reason may be that by taking part in risky ventures men are constantly trying to prove their fitness as a potential to be a deserving mate. However, females in following their inherent role as a homemaker prefer men who are cautious and thus may seem more stable.
'"/>




Page: 1

Related medicine news :

1. India takes on foot-and-mouth disease by vaccinating animals
2. Roller coaster takes brain for a big ride!!
3. Children! Protecting them from medical mistakes
4. Research on HIV takes new direction
5. Anorexia nervosa takes its toll on life!!
6. Deadly abortion pill takes two more lives
7. Young Women In Britain Overtakes Men In Drinking
8. Chicken takes a walk round the country side !
9. Jalgaon undertakes Culling of Two Lakh Birds
10. Costly mistakes help better understand OCD: obsessive compulsive disorder
11. FDA chief takes decision without two senior officials’ opinion
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: